ArticleResearch square2025

The PLK4 inhibitor RP-1664 demonstrates potent single-agent efficacy in neuroblastoma models through a dual mechanism of sensitivity.

John Maris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.